Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Dec 2022 |
---|---|---|---|---|
Total reported revenue | — | 12.4B | 8.0B | 13.3B |
Cost of revenue | — | 9.1B | 5.9B | 9.8B |
Gross profit | — | 3.3B | 2.1B | 3.4B |
Operating expense | ||||
Research & development | — | 775.6M | 438.0M | 608.9M |
Selling general and admin | — | -1.3B | 1.7B | -613.4M |
Other operating expenses | — | 79.3M | 47.6M | 85.1M |
Operating income | — | 1.3B | 951.0M | 1.7B |
Non operating interest income | ||||
Income | — | 402.1M | -133.5M | 391.0M |
Expense | — | -221.1M | 251.7M | -194.2M |
Other income expense | — | — | — | — |
Pretax income | — | 1.1B | 1.1B | 1.2B |
Tax provision | — | 81.0M | 211.2M | 64.3M |
Net income | — | 1.1B | 842.6M | 1.2B |
Basic EPS | 0.1 | — | — | — |
Diluted EPS | 0.1 | — | — | — |
Basic average shares | 83.4B | — | — | — |
Diluted average shares | 83.4B | — | — | — |
EBITDA | — | 1.3B | 1.3B | 1.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | -152.4M | -100.3M | -119.9M |
Preferred stock dividends | — | 0 | 0 | 0 |